J. M. Wenisch

Decreasing Clostridium difficile Infections by an Antimicrobial Stewardship Program That Reduces Moxifloxacin Use

J. M. Wenisch, Susanne Equiluz‐Bruck, Marta Fudel et al. · Antimicrobial Agents and Chemotherapy · 2014 · 59 citations · Full text

Moxifloxacin Restriction, Moxifloxacin Use, Antibiotic Resistance +23

A pilot study on reparixin, a CXCR1/2 antagonist, to assess safety and efficacy in attenuating ischaemia–reperfusion injury and inflammation after on-pump coronary artery bypass graft surgery

Philipp Opfermann, Ulla Derhaschnig, Alessia Felli et al. · Clinical & Experimental Immunology · 2014 · 49 citations · Full text

Hospital-acquired Clostridium difficile infection: determinants for severe disease

J. M. Wenisch, Daniela Schmid, Hung-Wei Kuo et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2011 · 48 citations

Severe Disease, Healthcare-associated Infection, Infection Control +3

Multiple-dose pharmacokinetics of daptomycin during continuous venovenous haemodiafiltration

J. M. Wenisch, B Meyer, Valentin Fuhrmann et al. · Journal of Antimicrobial Chemotherapy · 2011 · 42 citations · Full text

A prospective cohort study on hospital mortality due to Clostridium difficile infection

J. M. Wenisch, Daniela Schmid, Gerhard Tucek et al. · Infection · 2012 · 41 citations

Clostridium Difficile Infection, Hospital Mortality, Healthcare-associated Infection +9